Effect of dapagliflozin on COVID-19 infection and risk of hospitalization

BACKGROUND: Dapagliflozin has been proposed as a potential treatment for coronavirus disease 2019 (COVID-19) by reducing cytokine production and inflammation. However, there are limited data on its effectiveness. We aimed to evaluate the impact of dapagliflozin on COVID-19 severity (including hospit...

Descripción completa

Detalles Bibliográficos
Autores principales: Salgado-Barreira, Angel, Seijas-Amigo, Jose, Rodriguez-Mañero, Moises, Piñeiro-Lamas, María, Eiras, Sonia, Cordero, Alberto, Gonzalez-Juanatey, Jose Ramon, Figueiras, Adolfo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477113/
https://www.ncbi.nlm.nih.gov/pubmed/37549309
http://dx.doi.org/10.1093/jac/dkad241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477113/
https://www.ncbi.nlm.nih.gov/pubmed/37549309
http://dx.doi.org/10.1093/jac/dkad241

Ejemplares similares